» Articles » PMID: 37058185

Nutrition in Alzheimer's Disease: a Review of an Underappreciated Pathophysiological Mechanism

Overview
Specialties Biology
Science
Date 2023 Apr 14
PMID 37058185
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is the leading cause of dementia in older individuals and is an escalating challenge to global public health. Pharmacy therapy of AD is one of the well-funded areas; however, little progress has been made due to the complex pathogenesis. Recent evidence has demonstrated that modifying risk factors and lifestyle may prevent or delay the incidence of AD by 40%, which suggests that the management should pivot from single pharmacotherapy toward a multipronged approach because AD is a complex and multifaceted disease. Recently, the gut-microbiota-brain axis has gained tremendous traction in the pathogenesis of AD through bidirectional communication with multiple neural, immune, and metabolic pathways, providing new insights into novel therapeutic strategies. Dietary nutrition is an important and profound environmental factor that influences the composition and function of the microbiota. The Nutrition for Dementia Prevention Working Group recently found that dietary nutrition can affect cognition in AD-related dementia directly or indirectly through complex interactions of behavioral, genetic, systemic, and brain factors. Thus, considering the multiple etiologies of AD, nutrition represents a multidimensional factor that has a profound effect on AD onset and development. However, mechanistically, the effect of nutrition on AD is uncertain; therefore, optimal strategies or the timing of nutritional intervention to prevent or treat AD has not been established.Thus, this review summarizes the current state of knowledge concerning nutritional disorders, AD patient and caregiver burden, and the roles of nutrition in the pathophysiology of AD. We aim to emphasize knowledge gaps to provide direction for future research and to establish optimal nutrition-based intervention strategies for AD.

Citing Articles

Prevalence and correlation of sarcopenia with Alzheimer's disease: A systematic review and meta-analysis.

Su C, Zhang S, Zheng Q, Miao J, Guo J PLoS One. 2025; 20(3):e0318920.

PMID: 40029915 PMC: 11875368. DOI: 10.1371/journal.pone.0318920.


Malnutrition exacerbating neuropsychiatric symptoms on the Alzheimer's continuum is relevant to the cAMP signaling pathway: Human and mouse studies.

Jiang J, Jiang T, Wang X, Zhao M, Shi H, Zhang H Alzheimers Dement. 2025; 21(2):e14506.

PMID: 39868480 PMC: 11848410. DOI: 10.1002/alz.14506.


The microbiome's influence on obesity: mechanisms and therapeutic potential.

Tadese D, Mwangi J, Luo L, Zhang H, Huang X, Michira B Sci China Life Sci. 2024; 68(3):657-672.

PMID: 39617855 DOI: 10.1007/s11427-024-2759-3.


Alzheimer's Disease, Obesity, and Type 2 Diabetes: Focus on Common Neuroglial Dysfunctions (Critical Review and New Data on Human Brain and Models).

Toledano A, Rodriguez-Casado A, Alvarez M, Toledano-Diaz A Brain Sci. 2024; 14(11).

PMID: 39595866 PMC: 11591712. DOI: 10.3390/brainsci14111101.


Insulin-Like Growth Factor Signaling in Alzheimer's Disease: Pathophysiology and Therapeutic Strategies.

Miao J, Zhang Y, Su C, Zheng Q, Guo J Mol Neurobiol. 2024; 62(3):3195-3225.

PMID: 39240280 PMC: 11790777. DOI: 10.1007/s12035-024-04457-1.


References
1.
Aaldijk E, Vermeiren Y . The role of serotonin within the microbiota-gut-brain axis in the development of Alzheimer's disease: A narrative review. Ageing Res Rev. 2022; 75:101556. DOI: 10.1016/j.arr.2021.101556. View

2.
Abeysinghe A, Deshapriya R, Udawatte C . Alzheimer's disease; a review of the pathophysiological basis and therapeutic interventions. Life Sci. 2020; 256:117996. DOI: 10.1016/j.lfs.2020.117996. View

3.
Adeyemi O, Awakan O, Afolabi L, Rotimi D, Oluwayemi E, Otuechere C . Hypoxia and the Kynurenine Pathway: Implications and Therapeutic Prospects in Alzheimer's Disease. Oxid Med Cell Longev. 2021; 2021:5522981. PMC: 8598363. DOI: 10.1155/2021/5522981. View

4.
Akbari E, Asemi Z, Daneshvar Kakhaki R, Bahmani F, Kouchaki E, Tamtaji O . Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial. Front Aging Neurosci. 2016; 8:256. PMC: 5105117. DOI: 10.3389/fnagi.2016.00256. View

5.
Akyol S, Ugur Z, Yilmaz A, Ustun I, Gorti S, Oh K . Lipid Profiling of Alzheimer's Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism. Cells. 2021; 10(10). PMC: 8534054. DOI: 10.3390/cells10102591. View